A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 41,388 shares of CDNA stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,388
Previous 49,188 15.86%
Holding current value
$1.03 Million
Previous $763,000 69.33%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$14.41 - $33.99 $112,398 - $265,122
-7,800 Reduced 15.86%
41,388 $1.29 Million
Q2 2024

Jul 19, 2024

SELL
$7.56 - $16.15 $10,349 - $22,109
-1,369 Reduced 2.71%
49,188 $763,000
Q1 2024

Apr 22, 2024

SELL
$7.96 - $12.37 $2,069 - $3,216
-260 Reduced 0.51%
50,557 $535,000
Q4 2023

Jan 16, 2024

SELL
$4.9 - $12.86 $9,667 - $25,372
-1,973 Reduced 3.74%
50,817 $609,000
Q3 2023

Oct 24, 2023

SELL
$7.0 - $11.26 $280 - $450
-40 Reduced 0.08%
52,790 $369,000
Q2 2023

Jul 25, 2023

BUY
$7.61 - $9.46 $2,945 - $3,661
387 Added 0.74%
52,830 $449,000
Q1 2023

Apr 14, 2023

SELL
$8.83 - $17.61 $72,017 - $143,627
-8,156 Reduced 13.46%
52,443 $479,000
Q4 2022

Feb 08, 2023

BUY
$10.88 - $20.05 $49,699 - $91,588
4,568 Added 8.15%
60,599 $691,000
Q3 2022

Oct 25, 2022

BUY
$16.06 - $26.39 $10,117 - $16,625
630 Added 1.14%
56,031 $954,000
Q2 2022

Aug 12, 2022

SELL
$20.49 - $39.72 $97,757 - $189,504
-4,771 Reduced 7.93%
55,401 $1.19 Million
Q1 2022

May 11, 2022

SELL
$28.19 - $46.6 $251,595 - $415,905
-8,925 Reduced 12.92%
60,172 $2.23 Million
Q4 2021

Feb 08, 2022

BUY
$41.2 - $73.6 $478,785 - $855,305
11,621 Added 20.22%
69,097 $3.14 Million
Q3 2021

Nov 02, 2021

SELL
$59.15 - $91.99 $399,262 - $620,932
-6,750 Reduced 10.51%
57,476 $3.64 Million
Q2 2021

Aug 11, 2021

BUY
$63.02 - $95.11 $469,814 - $709,045
7,455 Added 13.13%
64,226 $5.88 Million
Q1 2021

May 14, 2021

BUY
$57.62 - $95.6 $199,710 - $331,349
3,466 Added 6.5%
56,771 $3.87 Million
Q4 2020

Feb 12, 2021

SELL
$41.43 - $77.09 $263,246 - $489,829
-6,354 Reduced 10.65%
53,305 $3.86 Million
Q3 2020

Nov 04, 2020

SELL
$30.88 - $37.94 $1.72 Million - $2.11 Million
-55,585 Reduced 48.23%
59,659 $2.26 Million
Q2 2020

Jul 17, 2020

SELL
$18.95 - $35.43 $2,577 - $4,818
-136 Reduced 0.12%
115,244 $4.08 Million
Q1 2020

Apr 21, 2020

BUY
$13.94 - $28.25 $747,825 - $1.52 Million
53,646 Added 86.9%
115,380 $2.52 Million
Q4 2019

Feb 12, 2020

BUY
$19.24 - $28.41 $436,132 - $643,997
22,668 Added 58.02%
61,734 $1.33 Million
Q3 2019

Nov 07, 2019

SELL
$20.03 - $40.08 $562,462 - $1.13 Million
-28,081 Reduced 41.82%
39,066 $883,000
Q2 2019

Aug 06, 2019

BUY
$25.78 - $39.77 $141,996 - $219,053
5,508 Added 8.94%
67,147 $2.42 Million
Q1 2019

May 06, 2019

BUY
$22.09 - $39.21 $914,393 - $1.62 Million
41,394 Added 204.47%
61,639 $1.94 Million
Q4 2018

Feb 11, 2019

SELL
$19.89 - $30.02 $270,504 - $408,272
-13,600 Reduced 40.18%
20,245 $509,000
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $63,525 - $151,462
-5,250 Reduced 13.43%
33,845 $976,000
Q2 2018

Jul 30, 2018

BUY
$7.93 - $15.79 $310,023 - $617,310
39,095 New
39,095 $479,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.33B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.